SHANGHAI, China--(BUSINESS WIRE)--GeneScience Pharmaceuticals Co., Ltd. (GenSci), a leading biopharmaceutical company in China focused on developing, manufacturing and marketing protein therapeutic products, including Somatropin, Filgrastim and Molgramostim, has been ranked number one in profitability among Chinese biopharmaceutical companies for the second quarter ended June 30, 2006, according to data compiled and released by the Chinese official agency, the National Bureau of Statistics.
